Update 1-Ardelyx bowel drug succeeds in mid-stage trial - Reuters

Update 1-Ardelyx bowel drug succeeds in mid-stage trialReuters(Adds details, shares). Oct 1 (Reuters) – Ardelyx Inc said its experimental drug to treat constipation-related irritable bowel syndrome achieved the main goal of increasing bowel movement compared with a placebo in a mid-stage study involving 371 patients.AstraZeneca partner Ardelyx scores a trial success for GI drugFierceBiotechArdelyx Reports…

Thumbnail for 7727

Fat can increase risk of cancer - iStreet Research

KY3 Fat can increase risk of canceriStreet Research2 Studies from the past have established possible link between fat and obesity to diabetes and cardiovascular disease but a new one added another risk for being obese- cancer. Advertisements. The American Society of Clinical Oncology and one of its …The link between fat and cancerWISN MilwaukeeBig Plans:…

Portola Pharma drug reverses effect of anti-clotting drugs in study - Reuters

Portola Pharma drug reverses effect of anti-clotting drugs in studyReuters(Reuters) – Portola Pharmaceuticals Inc said its drug met the main goal of reversing the effect of anti-coagulant drugs in a late-stage study. Data showed that an intravenous shot of the drug, andexanet alfa, immediately reversed the effect of Eliquis, …Portola Pharmaceuticals Announces Phase 3 ANNEXA(TM)-A…

Thumbnail for 7709

Ebola In Liberia: 'It'll Get Worse Before It Gets Better. And The Worse It Gets, The ... - Huffington Post

The Guardian Ebola In Liberia: ‘It’ll Get Worse Before It Gets Better. And The Worse It Gets, The …Huffington PostVictor Lacken is a photographer and communications delegate with the International Federation of Red Cross and Red Crescent Societies, who has just begun a three-month stay in Monrovia, Liberia. He shared with us his photos documenting…

Thumbnail for 7695

Vitamin D not a Protector Against Type 2 Diabetes: No substantial evidence found - Capital OTC

Capital OTC Vitamin D not a Protector Against Type 2 Diabetes: No substantial evidence foundCapital OTCA recent study by the researchers at the University Of Cambridge, UK defies the verdicts of past research that clinches that higher concentrations of circulating vitamin D might avoid type 2 diabetes. “Our findings suggest that interventions to reduce the…